TNF and endothelial dysfunction: Previous studies have reported that HO-1 is regulated by PPARγ agonists and that induction of HO-1 can prevent TNF-α induced endothelial dysfunction in vitro, which indicated that rosiglitazone may be responsible for protecting the vascular system via HO-1 and potentially anti-inflammatory mechanism [48].